Compile Data Set for Download or QSAR
Report error Found 35 Enz. Inhib. hit(s) with all data for entry = 13214
TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandPNGBDBM767400(1-[[3-[4-[4-[[2-allyl-3-oxo-1-(2- pyridyl)pyrazolo...)
Affinity DataEC50: <10nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandPNGBDBM767399(2-[1-[4-[[2-methyl-3-oxo-1-(2- pyridyl)pyrazolo[3,...)
Affinity DataEC50: <10nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandPNGBDBM767402(4-[[4-fluoro-3-[[4-[4-[[1-[6-(1- hydroxy-1-methyl-...)
Affinity DataEC50: <10nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandPNGBDBM767401(1-[[3-[[4-[4-[2-allyl-1-[6-(1- hydroxy-1-methyl-et...)
Affinity DataEC50: <10nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandPNGBDBM767396(2-[4-[[4-[4-[[2-allyl-3-oxo-1-(2- pyridyl)pyrazolo...)
Affinity DataEC50: <10nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandPNGBDBM767398(1-[[3-[4-[4-[[2-allyl-1-[6-(1-hydroxy- 1-methyl-et...)
Affinity DataEC50: <10nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandPNGBDBM767397(4-[[4-fluoro-3-[4-[4-[1-[6-(1- hydroxy-1-methyl-et...)
Affinity DataEC50: <10nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandPNGBDBM767390(4-[[3-[4-[4-[[2-allyl-1-[3-(1-hydroxy- 1-methyl-et...)
Affinity DataEC50: <10nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandPNGBDBM767416(6-fluoro-2-[4-[[4-[4-[[1-[6-(1- hydroxy-1-methyl-e...)
Affinity DataEC50:  55nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandPNGBDBM767415(6-fluoro-2-[4-[[4-[4-[[2-methyl-3- oxo-1-(2-pyridy...)
Affinity DataEC50:  55nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandPNGBDBM767418(4-[[4-fluoro-3-[4-[4-[[1-[6-(1- hydroxy-1-methyl-e...)
Affinity DataEC50:  55nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandPNGBDBM767408(4-[[4-fluoro-3-[4-[4-[(2-methyl-3- oxo-1-pyrimidin...)
Affinity DataEC50:  55nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandPNGBDBM767407(2-[4-[[4-[4-[2-allyl-1-[6-(1-hydroxy- 1-methyl-eth...)
Affinity DataEC50:  55nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandPNGBDBM767420(4-[[4-fluoro-3-[4-[4-[2-(2- methoxyethyl)-3-oxo-1-...)
Affinity DataEC50:  55nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandPNGBDBM767404(2-[1-[4-[2-methyl-3-oxo-1-(2- pyridyl)pyrazolo[3,4...)
Affinity DataEC50:  55nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandPNGBDBM767419(4-[[3-[[4-[4-[[2-allyl-1-[6-(1- hydroxy-1-methyl-e...)
Affinity DataEC50:  55nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandPNGBDBM767403(4-[[3-[4-[4-[[2-allyl-3-oxo-1-(2- pyridyl)pyrazolo...)
Affinity DataEC50:  55nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandPNGBDBM767406(2-[1-[4-[[2-methyl-3-oxo-1-(2- pyridyl)pyrazolo[3,...)
Affinity DataEC50:  55nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandPNGBDBM767405(5-fluoro-1-[[4-fluoro-3-[4-[4-[[2- methyl-3-oxo-1-...)
Affinity DataEC50:  55nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandPNGBDBM767423(2-[1-[4-[1-methyl-3-oxo-2-(2- pyridyl)pyrazolo[3,4...)
Affinity DataEC50:  550nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandPNGBDBM767422(2-[1-[4-[1-methyl-3-oxo-2-(2- pyridyl)pyrazolo[3,4...)
Affinity DataEC50:  550nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandPNGBDBM767417(6-fluoro-2-[4-[[4-[4-[[2-(2- methoxyethyl)-3-oxo-1...)
Affinity DataEC50:  550nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandPNGBDBM767421(4-[[4-fluoro-3-[4-[4-[[2-(2- hydroxyethyl)-3-oxo-1...)
Affinity DataEC50:  550nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandPNGBDBM767392(4-[[4-fluoro-3-[4-[4-[2-methyl-3- oxo-1-(2-pyridyl...)
Affinity DataEC50:  550nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandPNGBDBM767410(5-fluoro-1-[[4-fluoro-3-[4-[4-[(2- methyl-3-oxo-1-...)
Affinity DataEC50:  550nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandPNGBDBM767409(2-fluoro-5-[(5-fluoro-2,4-dioxo- quinazolin-1-yl)m...)
Affinity DataEC50:  550nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandPNGBDBM767424(2-[1-[4-[1-methyl-3-oxo-2-(2- pyridyl)pyrazolo[3,4...)
Affinity DataEC50: >1.00E+3nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandPNGBDBM767412(5-fluoro-1-[[4-fluoro-3-[4-[4-[[1- methyl-3-oxo-2-...)
Affinity DataEC50: >1.00E+3nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandPNGBDBM767395(N-[2-[2-allyl-1-[6-(1-hydroxy-1- methyl-ethyl)-2-p...)
Affinity DataEC50: >1.00E+3nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandPNGBDBM767411(4-[[4-fluoro-3-[4-[4-[[1-methyl-3- oxo-2-(2-pyridy...)
Affinity DataEC50: >1.00E+3nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandPNGBDBM767414(2-[4-[[4-[2-allyl-1-[6-(1-hydroxy-1- methyl-ethyl)...)
Affinity DataEC50: >1.00E+3nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandPNGBDBM767413(2-[4-[[4-[[2-allyl-1-[6-(1-hydroxy-1- methyl-ethyl...)
Affinity DataEC50: >1.00E+3nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandPNGBDBM767391(4-[[3-[4-[2-allyl-1-[6-(1-hydroxy-1- methyl-ethyl)...)
Affinity DataEC50: >1.00E+3nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandPNGBDBM767394(4-[[4-fluoro-3-[4-[2-methyl-3-oxo-1- (2-pyridyl)py...)
Affinity DataEC50: >1.00E+3nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandPNGBDBM767393(4-[[3-[4-[[2-allyl-1-[6-(1-hydroxy-1- methyl-ethyl...)
Affinity DataEC50: >1.00E+3nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent